All News Articles
USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S AND PARKINSON'S DISEASE
[8/6/2008]
Stable crystalline form of bifeprunox mesylate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
[8/6/2008]
Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
[8/6/2008]
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
[8/6/2008]
Obituaries
[8/6/2008]
National Parkinson Foundation Awards $3.7 Million in Grants
[8/6/2008]
ACADIA Pharmaceuticals Secures Committed Equity Financing Facility
[8/6/2008]
Obituaries
[8/5/2008]
Meda Acquires European Businesses from American Valeant and Enters the Russian Market
[8/5/2008]
Former Cove City mayor dies
[8/5/2008]
1
2
3
4
5
6
7
8
9
10
8/10
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Year
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Looking for Parkinson’s
news on a particular topic?
Search our news archives by typing your keyword into the field below and click “Go.”
Search
View All News Articles
